General Information of the Cell Line
Cell Line ID
CL000137
Cell Line Name
K562/A02
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0368
Tissue Information
Pleural effusion
Disease
Blast phase chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C9110)
Chronic myeloid leukemia (ORDO: Orphanet_521)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01546, ATP-dependent translocase ABCB1
Compound ID Compound Name Compound Formula
CP0543722
3-(4-chlorophenyl)-N-[4-(2-morpholin-4-ylethyl)phenyl]-4-oxophthalazine-1-carboxamide
   Show/Hide
C27H25ClN4O3
 8
1
EC50 = 65.31 nM
   TI
   LI
   LO
   TS
2
IC50 = 2410 nM
   TI
   LI
   LO
   TS
3
IC50 = 2460 nM
   TI
   LI
   LO
   TS
4
IC50 = 3150 nM
   TI
   LI
   LO
   TS
5
IC50 = 4310 nM
   TI
   LI
   LO
   TS
6
IC50 = 6620 nM
   TI
   LI
   LO
   TS
7
IC50 = 14270 nM
   TI
   LI
   LO
   TS
8
IC50 = 83680 nM
   TI
   LI
   LO
   TS
CP0389820
N-(4-tert-butylphenyl)-2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]benzamide
   Show/Hide
C33H39N5O4
 14
1
EC50 = 252.6 nM
   TI
   LI
   LO
   TS
2
IC50 = 1260 nM
   TI
   LI
   LO
   TS
3
IC50 = 1270 nM
   TI
   LI
   LO
   TS
4
IC50 = 3330 nM
   TI
   LI
   LO
   TS
5
IC50 = 4330 nM
   TI
   LI
   LO
   TS
6
IC50 = 6020 nM
   TI
   LI
   LO
   TS
7
IC50 = 6320 nM
   TI
   LI
   LO
   TS
8
IC50 = 10320 nM
   TI
   LI
   LO
   TS
9
IC50 = 12520 nM
   TI
   LI
   LO
   TS
10
IC50 = 17210 nM
   TI
   LI
   LO
   TS
11
IC50 = 18390 nM
   TI
   LI
   LO
   TS
12
IC50 = 34900 nM
   TI
   LI
   LO
   TS
13
IC50 = 37180 nM
   TI
   LI
   LO
   TS
14
IC50 = 37210 nM
   TI
   LI
   LO
   TS
CP0444582
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[[4-(furan-2-yl)pyrimidin-2-yl]amino]-4-methylbenzamide
   Show/Hide
C29H31N5O4
 10
1
EC50 = 1190 nM
   TI
   LI
   LO
   TS
2
IC50 = 180 nM
   TI
   LI
   LO
   TS
3
IC50 = 420 nM
   TI
   LI
   LO
   TS
4
IC50 = 4880 nM
   TI
   LI
   LO
   TS
5
IC50 = 16920 nM
   TI
   LI
   LO
   TS
6
IC50 = 25680 nM
   TI
   LI
   LO
   TS
7
IC50 = 38970 nM
   TI
   LI
   LO
   TS
8
IC50 = 45320 nM
   TI
   LI
   LO
   TS
9
IC50 = 76830 nM
   TI
   LI
   LO
   TS
10
IC50 = 84320 nM
   TI
   LI
   LO
   TS
CP0116921
1N-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolinyl)ethyl]phenyl}-4,5-dimethoxy-2-(3-quinolylcarboxamido)benzamide
   Show/Hide
C38H38N4O6
 7
1
IC50 = 460 nM
   TI
   LI
   LO
   TS
2
IC50 = 1600 nM
   TI
   LI
   LO
   TS
3
IC50 = 1970 nM
   TI
   LI
   LO
   TS
4
IC50 = 3020 nM
   TI
   LI
   LO
   TS
5
IC50 = 4970 nM
   TI
   LI
   LO
   TS
6
IC50 = 8280 nM
   TI
   LI
   LO
   TS
7
IC50 = 14390 nM
   TI
   LI
   LO
   TS
CP0002778
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
   Show/Hide
C29H31N7O
 1
1
IC50 = 580 nM
   TI
   LI
   LO
   TS
CP0531428
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[[4-(2-hydroxyphenyl)pyrimidin-2-yl]amino]-4-methylbenzamide
   Show/Hide
C31H33N5O4
 1
1
IC50 = 920 nM
   TI
   LI
   LO
   TS
CP0451088
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-4-methyl-3-[(4-thiophen-2-ylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C29H31N5O3S
 1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
CP0547994
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-methyl-3-[(4-phenylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C37H37N5O3
 1
1
IC50 = 1030 nM
   TI
   LI
   LO
   TS
CP0419245
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[[4-(3-hydroxyphenyl)pyrimidin-2-yl]amino]-4-methylbenzamide
   Show/Hide
C37H37N5O4
 1
1
IC50 = 1050 nM
   TI
   LI
   LO
   TS
CP0553197
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-4-methyl-3-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide
   Show/Hide
C32H35N5O3
 1
1
IC50 = 1180 nM
   TI
   LI
   LO
   TS
CP0534059
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-methyl-3-[(4-pyridin-2-ylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C36H36N6O3
 1
1
IC50 = 1220 nM
   TI
   LI
   LO
   TS
CP0532221
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[[4-(4-methoxyphenyl)pyrimidin-2-yl]amino]-4-methylbenzamide
   Show/Hide
C32H35N5O4
 1
1
IC50 = 1770 nM
   TI
   LI
   LO
   TS
CP0547996
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-methyl-3-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide
   Show/Hide
C38H39N5O3
 1
1
IC50 = 1950 nM
   TI
   LI
   LO
   TS
CP0547993
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[[4-(2-hydroxyphenyl)pyrimidin-2-yl]amino]-4-methylbenzamide
   Show/Hide
C37H37N5O4
 1
1
IC50 = 1980 nM
   TI
   LI
   LO
   TS
CP0444569
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-methyl-3-[(4-thiophen-2-ylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C35H35N5O3S
 1
1
IC50 = 2310 nM
   TI
   LI
   LO
   TS
CP0532223
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-4-methyl-3-[(4-phenylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C31H33N5O3
 1
1
IC50 = 2470 nM
   TI
   LI
   LO
   TS
CP0532225
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-hydroxy-4-oxochromene-2-carboxamide
   Show/Hide
C29H28N2O6
 1
1
IC50 = 2750 nM
   TI
   LI
   LO
   TS
CP0531430
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[[4-(4-fluorophenyl)pyrimidin-2-yl]amino]-4-methylbenzamide
   Show/Hide
C31H32FN5O3
 1
1
IC50 = 2950 nM
   TI
   LI
   LO
   TS
CP0531429
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[[4-(3-hydroxyphenyl)pyrimidin-2-yl]amino]-4-methylbenzamide
   Show/Hide
C31H33N5O4
 1
1
IC50 = 3010 nM
   TI
   LI
   LO
   TS
CP0552099
3-(4-chlorophenyl)-N-[(4-cyanophenyl)methyl]-4-oxophthalazine-1-carboxamide
   Show/Hide
C23H15ClN4O2
 1
1
IC50 = 3120 nM
   TI
   LI
   LO
   TS
CP0541483
4-tert-butyl-N-[2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]phenyl]benzamide
   Show/Hide
C33H39N5O4
 1
1
IC50 = 3420 nM
   TI
   LI
   LO
   TS
CP0532227
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-3-[[4-(4-fluorophenyl)pyrimidin-2-yl]amino]-4-methylbenzamide
   Show/Hide
C37H36FN5O3
 1
1
IC50 = 4020 nM
   TI
   LI
   LO
   TS
CP0541484
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-[4-(trifluoromethoxy)phenyl]benzamide
   Show/Hide
C30H30F3N5O5
 1
1
IC50 = 4520 nM
   TI
   LI
   LO
   TS
CP0543748
N-benzhydryl-3-(4-chlorophenyl)-4-oxophthalazine-1-carboxamide
   Show/Hide
C28H20ClN3O2
 1
1
IC50 = 5180 nM
   TI
   LI
   LO
   TS
CP0478387
N-(4-butylphenyl)-2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]benzamide
   Show/Hide
C33H39N5O4
 1
1
IC50 = 6250 nM
   TI
   LI
   LO
   TS
CP0543747
3-(4-chlorophenyl)-4-oxo-N-[[3-(trifluoromethoxy)phenyl]methyl]phthalazine-1-carboxamide
   Show/Hide
C23H15ClF3N3O3
 1
1
IC50 = 6350 nM
   TI
   LI
   LO
   TS
CP0036382
CAS_52-53-9
   Show/Hide
C27H38N2O4
 5
1
IC50 = 6470 nM
   TI
   LI
   LO
   TS
2
IC50 = 10730 nM
   TI
   LI
   LO
   TS
3
IC50 = 17250 nM
   TI
   LI
   LO
   TS
4
IC50 = 17550 nM
   TI
   LI
   LO
   TS
5
IC50 = 31280 nM
   TI
   LI
   LO
   TS
CP0451089
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-6-fluoro-4-oxochromene-2-carboxamide
   Show/Hide
C29H27FN2O5
 1
1
IC50 = 6620 nM
   TI
   LI
   LO
   TS
CP0532222
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-4-methyl-3-[(4-pyridin-2-ylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C30H32N6O3
 1
1
IC50 = 6900 nM
   TI
   LI
   LO
   TS
CP0465652
N-(4-chlorophenyl)-2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]benzamide
   Show/Hide
C29H30ClN5O4
 1
1
IC50 = 6930 nM
   TI
   LI
   LO
   TS
CP0576510
3-(4-chlorophenyl)-N-[4-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-oxophthalazine-1-carboxamide
   Show/Hide
C32H27ClN4O2
 1
1
IC50 = 6930 nM
   TI
   LI
   LO
   TS
CP0410563
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(4-methylphenyl)benzamide
   Show/Hide
C30H33N5O4
 1
1
IC50 = 7650 nM
   TI
   LI
   LO
   TS
CP0410565
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(3,4-dimethoxyphenyl)benzamide
   Show/Hide
C31H35N5O6
 1
1
IC50 = 7820 nM
   TI
   LI
   LO
   TS
CP0465651
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(4-fluorophenyl)benzamide
   Show/Hide
C29H30FN5O4
 1
1
IC50 = 8290 nM
   TI
   LI
   LO
   TS
CP0478388
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(4-methoxyphenyl)benzamide
   Show/Hide
C30H33N5O5
 1
1
IC50 = 8380 nM
   TI
   LI
   LO
   TS
CP0451522
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(3-methoxyphenyl)benzamide
   Show/Hide
C30H33N5O5
 1
1
IC50 = 8730 nM
   TI
   LI
   LO
   TS
CP0576506
N-(1H-benzimidazol-2-yl)-3-(4-chlorophenyl)-4-oxophthalazine-1-carboxamide
   Show/Hide
C22H14ClN5O2
 1
1
IC50 = 9350 nM
   TI
   LI
   LO
   TS
CP0532224
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-oxochromene-2-carboxamide
   Show/Hide
C29H28N2O5
 1
1
IC50 = 9610 nM
   TI
   LI
   LO
   TS
CP0576508
3-(4-chlorophenyl)-4-oxo-N-[(3,4,5-trimethoxyphenyl)methyl]phthalazine-1-carboxamide
   Show/Hide
C25H22ClN3O5
 1
1
IC50 = 10410 nM
   TI
   LI
   LO
   TS
CP0465650
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(3-methylphenyl)benzamide
   Show/Hide
C30H33N5O4
 1
1
IC50 = 12160 nM
   TI
   LI
   LO
   TS
CP0576505
3-(4-chlorophenyl)-N-[4-(4-methylpiperazin-1-yl)phenyl]-4-oxophthalazine-1-carboxamide
   Show/Hide
C26H24ClN5O2
 1
1
IC50 = 12280 nM
   TI
   LI
   LO
   TS
CP0543746
3-(4-chlorophenyl)-N-(2-morpholin-4-ylethyl)-4-oxophthalazine-1-carboxamide
   Show/Hide
C21H21ClN4O3
 1
1
IC50 = 13620 nM
   TI
   LI
   LO
   TS
CP0571178
3-(4-chlorophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-4-oxophthalazine-1-carboxamide
   Show/Hide
C25H22ClN3O4
 1
1
IC50 = 13790 nM
   TI
   LI
   LO
   TS
CP0576759
3-(4-chlorophenyl)-N-(4-morpholin-4-ylphenyl)-4-oxophthalazine-1-carboxamide
   Show/Hide
C25H21ClN4O3
 1
1
IC50 = 14460 nM
   TI
   LI
   LO
   TS
CP0036082
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
   Show/Hide
C22H24ClFN4O3
 1
1
IC50 = 19970 nM
   TI
   LI
   LO
   TS
CP0578337
N,N-dibenzyl-3-(4-chlorophenyl)-4-oxophthalazine-1-carboxamide
   Show/Hide
C29H22ClN3O2
 1
1
IC50 = 20610 nM
   TI
   LI
   LO
   TS
CP0390060
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(4-nitrophenyl)benzamide
   Show/Hide
C29H30N6O6
 1
1
IC50 = 21070 nM
   TI
   LI
   LO
   TS
CP0410562
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(2-methylphenyl)benzamide
   Show/Hide
C30H33N5O4
 1
1
IC50 = 21910 nM
   TI
   LI
   LO
   TS
CP0572938
3-(4-chlorophenyl)-4-oxo-N-(2-phenylethyl)phthalazine-1-carboxamide
   Show/Hide
C23H18ClN3O2
 1
1
IC50 = 22730 nM
   TI
   LI
   LO
   TS
CP0495662
N-(3-chlorophenyl)-2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]benzamide
   Show/Hide
C29H30ClN5O4
 1
1
IC50 = 22820 nM
   TI
   LI
   LO
   TS
CP0576760
3-(4-chlorophenyl)-N-[(4-methoxyphenyl)methyl]-4-oxophthalazine-1-carboxamide
   Show/Hide
C23H18ClN3O3
 1
1
IC50 = 24280 nM
   TI
   LI
   LO
   TS
CP0410564
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-phenylbenzamide
   Show/Hide
C29H31N5O4
 1
1
IC50 = 25520 nM
   TI
   LI
   LO
   TS
CP0523551
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(2-nitrophenyl)benzamide
   Show/Hide
C29H30N6O6
 1
1
IC50 = 26920 nM
   TI
   LI
   LO
   TS
CP0410560
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(3-nitrophenyl)benzamide
   Show/Hide
C29H30N6O6
 1
1
IC50 = 27690 nM
   TI
   LI
   LO
   TS
CP0475330
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(3,4,5-trimethoxyphenyl)benzamide
   Show/Hide
C32H37N5O7
 1
1
IC50 = 31920 nM
   TI
   LI
   LO
   TS
CP0576509
3-(4-chlorophenyl)-4-oxo-N-(pyridin-4-ylmethyl)phthalazine-1-carboxamide
   Show/Hide
C21H15ClN4O2
 1
1
IC50 = 34750 nM
   TI
   LI
   LO
   TS
CP0569303
3-(4-chlorophenyl)-4-oxo-N-[(4-phenylphenyl)methyl]phthalazine-1-carboxamide
   Show/Hide
C28H20ClN3O2
 1
1
IC50 = 35120 nM
   TI
   LI
   LO
   TS
CP0568028
3-(4-chlorophenyl)-N-[2-(3-fluorophenyl)ethyl]-4-oxophthalazine-1-carboxamide
   Show/Hide
C23H17ClFN3O2
 1
1
IC50 = 46320 nM
   TI
   LI
   LO
   TS
CP0576507
3-(4-chlorophenyl)-N-[2-(3-chlorophenyl)ethyl]-4-oxophthalazine-1-carboxamide
   Show/Hide
C23H17Cl2N3O2
 1
1
IC50 = 46540 nM
   TI
   LI
   LO
   TS
CP0574618
3-(4-chlorophenyl)-4-oxo-N-(pyridin-3-ylmethyl)phthalazine-1-carboxamide
   Show/Hide
C21H15ClN4O2
 1
1
IC50 = 50900 nM
   TI
   LI
   LO
   TS
CP0543855
3-(4-chlorophenyl)-N-(3-morpholin-4-ylpropyl)-4-oxophthalazine-1-carboxamide
   Show/Hide
C22H23ClN4O3
 1
1
IC50 = 65560 nM
   TI
   LI
   LO
   TS
CP0444570
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-7-methyl-4-oxochromene-2-carboxamide
   Show/Hide
C30H30N2O5
 1
1
IC50 = 84850 nM
   TI
   LI
   LO
   TS
CP0141589
3-((3S,6S)-6-Isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)-propionic acid tert-butyl ester
   Show/Hide
C26H35N3O5
 1
1
IC50 = 86790 nM
   TI
   LI
   LO
   TS
CP0664710
SID49681823
   Show/Hide
C27H30ClNO11
 1
1
IC50 = 96910 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0036382
CAS_52-53-9
   Show/Hide
C27H38N2O4  1
1
IC50 = 56240 nM
   TI
   LI
   LO
   TS
CP0390060
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(4-nitrophenyl)benzamide
   Show/Hide
C29H30N6O6  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0410562
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(2-methylphenyl)benzamide
   Show/Hide
C30H33N5O4  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0410563
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(4-methylphenyl)benzamide
   Show/Hide
C30H33N5O4  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0444569
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-methyl-3-[(4-thiophen-2-ylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C35H35N5O3S  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0475330
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(3,4,5-trimethoxyphenyl)benzamide
   Show/Hide
C32H37N5O7  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0523551
2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]-N-(2-nitrophenyl)benzamide
   Show/Hide
C29H30N6O6  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0532222
N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-4-methyl-3-[(4-pyridin-2-ylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C30H32N6O3  1
1
IC50 = 89620 nM
   TI
   LI
   LO
   TS
CP0541483
4-tert-butyl-N-[2-[[1-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]triazol-4-yl]methoxy]phenyl]benzamide
   Show/Hide
C33H39N5O4  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0545962
N-(4-morpholin-4-ylphenyl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide
   Show/Hide
C22H23N5O2  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0547996
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-methyl-3-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide
   Show/Hide
C38H39N5O3  1
1
IC50 = 9533000 nM
   TI
   LI
   LO
   TS
CP0664710
SID49681823
   Show/Hide
C27H30ClNO11  1
1
IC50 = 96910 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Pleural effusion)
Cell Line Name Organism Disease
U-937 Homo sapiens (Human) Adult acute monocytic leukemia
SU-DHL-1 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
SR Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
MC116 Homo sapiens (Human) B-cell non-Hodgkin lymphoma
K-562 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/Adr Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/R7 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/DOX Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
MDA-MB-231 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-415 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-468 Homo sapiens (Human) Breast adenocarcinoma
SK-BR-3 Homo sapiens (Human) Breast adenocarcinoma
AU565 Homo sapiens (Human) Breast adenocarcinoma
CAL-51 Homo sapiens (Human) Breast carcinoma
CAL-120 Homo sapiens (Human) Breast carcinoma
DG-75 Homo sapiens (Human) Burkitt lymphoma
SUP-T1 Homo sapiens (Human) Childhood T lymphoblastic lymphoma
Pfeiffer Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
WSU-DLCL2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
Karpas-422 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
DoHH2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
KATO III Homo sapiens (Human) Down syndrome
GIST-T1 Homo sapiens (Human) Gastrointestinal stromal tumor
GIST-5R Homo sapiens (Human) Gastrointestinal stromal tumor
MZ-CRC-1 Homo sapiens (Human) Hereditary thyroid gland medullary carcinoma
L-428 Homo sapiens (Human) Hodgkin lymphoma
KM-H2 Homo sapiens (Human) Hodgkin lymphoma
T-47D Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T-47 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 MX100 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/VP Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D:A18 Homo sapiens (Human) Invasive breast carcinoma of no special type
MVLN Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF/MX Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/Topo Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7aro Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M6 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-10 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7piGST Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-Y1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/ADM Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7:WS8 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-FLV1000 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-neo/Her2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 cl.24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/DX1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-LC3 Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D-KBluc Homo sapiens (Human) Invasive breast carcinoma of no special type
Calu-6 Homo sapiens (Human) Lung adenocarcinoma
Calu-3 Homo sapiens (Human) Lung adenocarcinoma
HCC78 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3122 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3255 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2122 Homo sapiens (Human) Lung adenocarcinoma
COR-L105 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1437 Homo sapiens (Human) Lung adenocarcinoma
HCC4006 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1792 Homo sapiens (Human) Lung adenocarcinoma
DFCI032 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1355 Homo sapiens (Human) Lung adenocarcinoma
NCI-H460 Homo sapiens (Human) Lung large cell carcinoma
U-1810 Homo sapiens (Human) Lung large cell carcinoma
COR-L23/R Homo sapiens (Human) Lung large cell carcinoma
H460/MX20 Homo sapiens (Human) Lung large cell carcinoma
H460R Homo sapiens (Human) Lung large cell carcinoma
H69AR Homo sapiens (Human) Lung small cell carcinoma
NCI-H69 Homo sapiens (Human) Lung small cell carcinoma
GLC-4/ADR Homo sapiens (Human) Lung small cell carcinoma
STC 1 Homo sapiens (Human) Lung small cell carcinoma
RERF-LC-A1 Homo sapiens (Human) Lung squamous cell carcinoma
Calu-1 Homo sapiens (Human) Lung squamous cell carcinoma
HCC95 Homo sapiens (Human) Lung squamous cell carcinoma
RERF-LC-AI Tet-off Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1650 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H1666 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H929 Homo sapiens (Human) Plasma cell myeloma
KMS-11 Homo sapiens (Human) Plasma cell myeloma
UTMC-2 Homo sapiens (Human) Plasma cell myeloma
KMS-12-PE Homo sapiens (Human) Plasma cell myeloma
NCI-H226 Homo sapiens (Human) Pleural epithelioid mesothelioma
Karpas-1106P Homo sapiens (Human) Primary mediastinal (thymic) large B-cell lymphoma